GMRE (Global Medical REIT) Valuation Rank

View and export this data going back to 2012. Start your Free Trial

What is Global Medical REIT Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Global Medical REIT Valuation Rank Related Terms

Thank you for viewing the detailed overview of Global Medical REIT's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Medical REIT Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Global Medical REIT Inc (NYSE:GMRE) » Definitions » Valuation Rank

Comparable Companies

UHT DHC CHTH CHCT HLTC AHTR NHHS CVMCA STRW LTC WELL VTR PEAK OHI HR SBRA MPW DOC XBRU:AED NHI

Traded in Other Exchanges

GMREpA.PFD:USA 3UN:Germany

Address

7373 Wisconsin Avenue, Suite 800, Bethesda, MD, USA, 20814

Website

https://www.globalmedicalreit.com

Global Medical REIT Inc is a Maryland corporation engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.

Executives

Moore Roscoe M Jr	director	C/O HEMOBIOTECH, INC., 5001 SPRING VALLEY ROAD, SUITE 1040 WEST, DALLAS TX 75244
Henry Cole	director	4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Jeffrey Busch	director, officer: Chairman, President and CEO	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Lori Wittman	director	191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606
Matthew Cypher	director	4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Paula Crowley	director	2 BETHESDA METRO CENTER, SUITE 440, BETHESDA MD 20814
Ronald Marston	director	4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Robert J Kiernan	officer: Chief Financial Officer	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Alfonzo Leon	officer: Chief Investment Officer	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Danica Holley	officer: Chief Operating Officer	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Jamie Allen Barber	officer: Secretary and General Counsel	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Allen Webb	officer: SVP	4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Huiqi Zhang	director, 10 percent owner	40-44 WYNDHAM STREET, 24/F WYNDHAM PLACE, HONG KONG K3 00000
Notable Reward Ltd	10 percent owner	VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110
Superior Glory Enterprises Ltd.	10 percent owner	VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110